ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine fumarate - 200mg | 7856 | 186124/13 | REZAL XR | 200mg | 30 | Tablet, extended release | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2,116,552 L.L | 23.08 | B | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |